<DOC>
	<DOCNO>NCT00735553</DOCNO>
	<brief_summary>Premenopausal woman symptomatic uterine fibroid randomize either Proellex 25mg 50mg placebo one treatment cycle ( four month ) . Safety effectiveness 50 mg versus placebo , 25mg placebo analyze .</brief_summary>
	<brief_title>Evaluating Safety Efficacy ProellexÂ® ( CDB-4124 ) Premenopausal Women With Symptomatic Uterine Fibroids</brief_title>
	<detailed_description>Subjects document uterine fibroid , screen UFS-QOL severity score least 40 , meet eligibility criterion enrol study . Following screen pre-treatment endometrial biopsy , subject assess monthly four ( 4 ) month double-blinded treatment phase . The study duration approximately six month , comprise one-month screening period , 4 month treatment period one month follow-up period . Subjects ' blood drawn fast state obtain pre-dose trough ( PK ) level study drug study drug dosing/dispensation visit determine potential drug accumulation .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Speak , read understand English Spanish ; Not undergone hysterectomy , uterine arterial embolization endometrial ablation therapy ( previous myomectomy acceptable ) cause surgical intervention uterine fibroid ( e.g . hysterectomy , myomectomy , uterine arterial embolization ) plan anticipate study ; One uterine fibroid must identifiable measurable transvaginal ultrasound ; Menstrual cycle last 24 36 day ; History excessive menstrual bleeding ; Negative urine pregnancy test screening . Six month ( immediately prior Screening Visit ) without menstrual period ; Prior hysterectomy ; Prior bilateral oophorectomy ; Pregnant lactate female woman attempt expect become pregnant time study ; Documented endometriosis , active pelvic inflammatory disease ( PID ) , platelet dysfunction , Von Willebrand 's Disease ; Any history diagnosis gynecological cancer cervical dysplasia grade include atypical squamous cell undetermined significance ( ASCUS ) associate Human Papilloma Virus ( HPV ) ; Subject diagnose suspect carcinoma breast , reproductive organ organ system ; Subject know active infection HIV , Hepatitis A , B C , Gonorrhea , Chlamydia previous history autoimmune disease positive serum antinuclear antibody .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Uterine Fibroids</keyword>
</DOC>